SEP 24, 2014 2:00 PM PDT

Development and Applications of CRISPR-Cas9 for Genome Editing

Speakers
  • Core Member, Broad Institute of MIT and Harvard; Investigator, McGovern Institute for Brain Research; W. M. Keck Career Development Professor in Biomedical Engineering, MIT
    Biography

       
      Feng Zhang joined the Broad Institute of MIT and Harvard as a core member in January 2011, combining technology development and application to study the role of genetic and epigenetic mechanisms underlying diseases specifically of the nervous system. Along with Jennifer Doudna, George Church, Keith Joung and David Liu, Zhang is a co-founder of Editas Medicine.
      As a graduate student at Stanford, Zhang worked with Karl Deisseroth to invent technologies for dissecting the functional organization of brain circuits. He served as a Junior Fellow at Harvard and did postdoctoral research using synthetic biology to study gene activity during brain development. At the Broad, Zhang takes a synthetic biology approach to understand the development of neuropsychiatric disease, is developing novel genome editing technologies including CRISPR aimed at developing specialized animal models. Zhang is also an investigator at the McGovern Institute for Brain Research at MIT.
      He is a recipient of the Perl/UNC Prize in Neuroscience, the NIH Director's Pioneer award, and the National Science Foundation's Alan T. Waterman award. He has also received technology innovation awards from the McKnight and Damon Runyon foundations, and the International Society for Transgenic Technologies. He received his A.B. in chemistry and physics from Harvard College and his Ph.D. in chemistry from Stanford University.
       
       

    Abstract:

    The RNA-guided nuclease Cas9 from the microbial CRISPR adaptive immune system has emerged as an exciting tool for precise genome editing in eukaryotic cells. This presentation will discuss the technical development as well as current and future applications and challenges.


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    Loading Comments...
    Show Resources